Search for: "Williams v. Eli Lilly and Company"
Results 1 - 20
of 25
Sorted by Relevance
|
Sort by Date
4 Apr 2007, 10:19 am
Eli Lilly & Co. [read post]
28 Oct 2013, 1:12 pm
” (United States v. [read post]
2 Nov 2011, 5:40 am
Supreme Court Rainy Sky SA & Orsd v Kookmin Bank [2011] UKSC 50 (2 November 2011) Human Genome Sciences Inc v Eli Lilly and Company [2011] UKSC 51 (2 November 2011) Court of Appeal (Civil Division) MD (Angola) & Ors, R (on the application of) v Secretary of State for the Home Department & Anor [2011] EWCA Civ 1238 (01 November 2011) Mitu v London Borough of Camden [2011] EWCA civ 1249 (01 November 2011) Williams… [read post]
21 Jun 2018, 8:02 am
Lilly-v-Arla-Opinion [read post]
Seventh Circuit Upholds Preliminary Injunction Issued in Favor of Elanco US, Inc. Against Arla Foods
21 Jun 2018, 8:02 am
Lilly-v-Arla-Opinion [read post]
11 Dec 2008, 10:30 pm
Eli Lilly & Co. v. [read post]
1 Apr 2008, 10:57 am
Williams v. [read post]
17 May 2018, 1:36 pm
Having presided over major decisions impacting both on IP law and practice, not the least Actavis v Eli Lilly, Baron Neuberger will be sharing his insights and reflections on “IP in the UK and Europe – a view from the top”. [read post]
18 Jul 2014, 11:55 am
Clay v. [read post]
20 Mar 2009, 2:05 am
Eli Lilly & Co., 774 F.2d 830, 835 (7th Cir. 1985); Martinkovic v. [read post]
31 Jan 2007, 9:51 am
Eli Lilly and Company - employment issues, more coming Marietta Squibb v. [read post]
14 Jun 2007, 12:57 am
Eli Lilly: Lawyers' Ads Are Hurting Patients
The Associated Press
Eli Lilly and Co., which has faced thousands of suits over its anti-psychotic Zyprexa, says lawyers' ads about the drug are prompting patients to stop taking mental illness medications when they shouldn't. [read post]
19 Sep 2013, 9:53 am
By itself, off-label promotion is no more causal than, as we commented the other day, a “video of a company employee kicking his dog. [read post]
20 May 2012, 1:11 pm
Joining Director Kappos was the Senior Vice President and General Counsel of Eli Lilly, Robert Armitage (read his written testimony here), General Electric's Chief IP Counsel, Car"l Horton (read his written testimony here), President and Chief IP Counsel of 3M Innovative Properties, Kevin Rhodes (read his written testimony here), Richard Brandon, Associate General Counsel of the University of Michigan on behalf of the Association of American Universities… [read post]
23 Dec 2007, 8:00 pm
: (IPKat),Amazon gift ordering patent revoked by the EPO: (OUT-LAW), (IP Law360)Legal protection for databases: case report on dispute between the British Horseracing Board and William Hill: (OUT-LAW),Court of First Instance rejects Enercon's appeal to register a football-shaped wind turbine as a Community trade mark: (Mondaq.com),More on registrability of Tarzan's yell as a trade mark at OHIM: (OUT-LAW), (more from OUT-LAW),Gateway Inc. cannot… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co… [read post]
15 Jan 2008, 3:06 am
Varden et al filed 04/24/07 closed 12/13/07 1:07-cv-02382 William Reber, L.L.C. v. [read post]
17 Jun 2010, 5:00 am
Eli Lilly & Co., 696 N.E.2d 187 (Ohio 1998)) and a gun case in New York (Hamilton v. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
6 Jul 2007, 4:29 am
Thus, at best, Karl has just created a regime of redundant and overlapping liability with the patients stuck in the middle - not knowing whom to believe if doctors and drug companies say different things.The learned intermediary rule thus makes sound practical sense. [read post]
